Your browser doesn't support javascript.
loading
Novel grading system for CADASIL severity: A multicenter cross-sectional study.
Anisetti, Bhrugun; Greco, Elena; Stojadinovic, Eldina; Goldstein, Eric D; Sakusic, Amra; Badi, Mohammed K; Liu, Michael D; Lin, Michelle P; Chiang, Chia-Chun; Elahi, Fanny M; Worrall, Bradford B; Petrosian, Derek; Ross, Owen; Meschia, James F.
Afiliación
  • Anisetti B; Department of Neurology, Mayo Clinic, Jacksonville, FL, USA.
  • Greco E; Department of Neurology, Mayo Clinic, Jacksonville, FL, USA.
  • Stojadinovic E; Department of Neurology, Mayo Clinic, Jacksonville, FL, USA.
  • Goldstein ED; Department of Neurology, Warren Alpert Medical School of Brown University, Providence, RI, USA.
  • Sakusic A; Department of Neurology, Mayo Clinic, Jacksonville, FL, USA.
  • Badi MK; Department of Neurology, Mayo Clinic, Jacksonville, FL, USA.
  • Liu MD; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Lin MP; Department of Neurology, Mayo Clinic, Jacksonville, FL, USA.
  • Chiang CC; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Elahi FM; Department of Neurology, University of California, San Francisco, California, USA.
  • Worrall BB; Department of Neurology, University of Virginia, Charlottesville, Virginia, USA.
  • Petrosian D; Department of Neurology, University of Virginia, Charlottesville, Virginia, USA.
  • Ross O; Mayo Clinic College of Medicine and Science, Mayo Clinic, Jacksonville, Florida, USA.
  • Meschia JF; Department of Neurology, Mayo Clinic, Jacksonville, FL, USA.
Cereb Circ Cogn Behav ; 5: 100170, 2023.
Article en En | MEDLINE | ID: mdl-37441712
ABSTRACT

Background:

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an inherited progressive cerebral microangiopathy with considerable phenotypic variability. The purpose of this study was to describe the generalizability of a recently proposed grading system of CADASIL across multiple centers in the United States.

Methods:

Electronic medical records (EMR) of an initial neurological assessment of adult patients with confirmed CADASIL were reviewed across 5 tertiary referral medical centers with expertise in CADASIL. Demographic, vascular risk factors, and neuroimaging data were abstracted from EMR. Patients were categorized into groups according to the proposed CADASIL grading system Grade 0 (asymptomatic), Grade 1 (migraine only), Grade 2 (stroke, TIA, or MCI), Grade 3 (gait assistance or dementia), and Grade 4 (bedbound or end-stage). Inter-rater reliability (IRR) of grading was tested in a subset of cases.

Results:

We identified 138 patients with a mean age of 50.9 ± 13.1 years, and 57.2% were female. The IRR was acceptable over 33 cases (κ=0.855, SD 0.078, p<0.001) with 81.8% being concordant. There were 15 patients (10.9%) with Grade 0, 50 (36.2%) with Grade 1, 61 (44.2%) with Grade 2, 12 (8.7%) with Grade 3, and none with Grade 4. Patients with a lower severity grade (grade 0 vs 3) tended to be younger (49.5 vs. 61.9 years) and had a lower prevalence of hypertension (50% vs. 20%, p = 0.027) and diabetes mellitus (0% vs. 25%, p = 0.018). A higher severity grade was associated with an increased number of vascular risk factors (p = 0.02) and independently associated with hypertension and diabetes (p<0.05). Comparing Grade 0 vs. 3, cortical thickness tended to be greater (2.06 vs. 1.87 mm; p = 0.06) and white matter hyperintensity volume tended to be lower (54.7 vs. 72.5 ml; p = 0.73), but the differences did not reach significance.

Conclusion:

The CADASIL severity grading system is a pragmatic, reliable system for characterizing CADASIL phenotype that does not require testing beyond that done in standard clinical practice. Higher severity grades tended to have a higher vascular risk factor burden. This system offers a simple method of categorizing CADASIL patients which may help to describe populations in observational and interventional studies.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cereb Circ Cogn Behav Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cereb Circ Cogn Behav Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos